Dr Janet Michelle Stallman, MD | |
One Hoag Drive, Newport Beach, CA 92658-6100 | |
(949) 764-5610 | |
Not Available |
Full Name | Dr Janet Michelle Stallman |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 33 Years |
Location | One Hoag Drive, Newport Beach, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245276476 | NPI | - | NPPES |
00A540880 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | A54088 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hoag Memorial Hospital Presbyterian | Newport beach, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Newport Harbor Pathology Medical Group Inc | 1456312396 | 28 |
News Archive
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
Eating more n-3 polyunsaturated fatty acids, commonly known as omega-3 fatty acids, may help carriers of a genetic variant on the perilipin 4 (PLIN4) gene locus lose weight more efficiently.
Fresh insights into the structures that contain our genetic material could explain how the body's cells stay healthy.
A study published in the May/June issue of Health Affairs reports on the first randomized trial providing a scientifically valid look at what one might expect from chronic disease management programs that serve low-income individuals. The study result provides good news for state Medicaid leaders struggling to meet the needs of individuals with chronic conditions and also suggests that some disease management efforts, even among relatively low-risk patients, may be an effective strategy.
› Verified 5 days ago
Entity Name | Newport Harbor Pathology Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790711927 PECOS PAC ID: 1456312396 Enrollment ID: O20041022001124 |
News Archive
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
Eating more n-3 polyunsaturated fatty acids, commonly known as omega-3 fatty acids, may help carriers of a genetic variant on the perilipin 4 (PLIN4) gene locus lose weight more efficiently.
Fresh insights into the structures that contain our genetic material could explain how the body's cells stay healthy.
A study published in the May/June issue of Health Affairs reports on the first randomized trial providing a scientifically valid look at what one might expect from chronic disease management programs that serve low-income individuals. The study result provides good news for state Medicaid leaders struggling to meet the needs of individuals with chronic conditions and also suggests that some disease management efforts, even among relatively low-risk patients, may be an effective strategy.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Janet Michelle Stallman, MD Po Box 6100, Pathology, Newport Beach, CA 92658-6100 Ph: () - | Dr Janet Michelle Stallman, MD One Hoag Drive, Newport Beach, CA 92658-6100 Ph: (949) 764-5610 |
News Archive
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
Eating more n-3 polyunsaturated fatty acids, commonly known as omega-3 fatty acids, may help carriers of a genetic variant on the perilipin 4 (PLIN4) gene locus lose weight more efficiently.
Fresh insights into the structures that contain our genetic material could explain how the body's cells stay healthy.
A study published in the May/June issue of Health Affairs reports on the first randomized trial providing a scientifically valid look at what one might expect from chronic disease management programs that serve low-income individuals. The study result provides good news for state Medicaid leaders struggling to meet the needs of individuals with chronic conditions and also suggests that some disease management efforts, even among relatively low-risk patients, may be an effective strategy.
› Verified 5 days ago
Dr. Howard D Epstein, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Drive, Newport Beach, CA 92658 Phone: 949-764-5635 Fax: 949-764-8083 | |
John Cupp, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2901 W. Coast Hwy, Suite 200, Newport Beach, CA 92663 Phone: 949-891-1297 Fax: 949-625-8010 | |
Dr. Arell Shapiro, M.D. Pathology Medicare: Medicare Enrolled Practice Location: One Hoag Drive, Newport Beach, CA 92658 Phone: 949-764-6189 Fax: 949-764-8317 | |
Veronica Rausei-mills, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Department Of Pathology, Newport Beach, CA 92663 Phone: 949-764-5610 | |
Mani Ehteshami, MD Pathology Medicare: Medicare Enrolled Practice Location: 27 Clermont, Newport Beach, CA 92657 Phone: 949-706-2796 Fax: 949-706-2072 | |
Thomas Randal Heinz, M. D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Hoag Dr, Department Of Pathology, Newport Beach, CA 92663 Phone: 949-764-5610 |